The prolonged survival of patients with HIV as a result of improved medical therapies, such as highly active antiretroviral therapy, has led to an increased number of these patients developing non-AIDS-defining malignancies, including prostate cancer. The management of HIV-positive patients with prostate cancer is discussed in this Review.
- Matthew S. Wosnitzer
- Franklin C. Lowe